Inhibition of two-step urinary bladder carcinogenesis by the somatostatin analogue RC-160
- 1 October 1992
- journal article
- research article
- Published by Springer Nature in Urological Research
- Vol. 20 (6) , 383-386
- https://doi.org/10.1007/bf00294492
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Release of peptides from sustained delivery systems (microcapsules and microparticles) in vivoInternational Journal of Peptide and Protein Research, 1990
- Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review.1990
- Epidermal Growth Factor Receptor in Human Bladder Cancer: A Comparison of Immunohistochemistry and Ligand BindingJournal of Urology, 1989
- Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase.Proceedings of the National Academy of Sciences, 1989
- Promotion of urinary bladder carcinogenesis in experimental animalsExperimental pathology, 1989
- Oncological applications of somatostatin analogues.1988
- Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.Proceedings of the National Academy of Sciences, 1987
- Growth factors and cancer.1986
- UROTHELIAL DYSPLASIA CONCOMITANT WITH BLADDER TUMOURS AS A DETERMINANT FACTOR FOR FUTURE NEW OCCURRENCESThe Lancet, 1983
- HISTOPATHOLOGICAL ANALYSIS OF PRENEOPLASTIC CHANGES DURING N‐BUTYL‐N‐(4‐HYDROXYBUTYL)‐ NITROSAMINE‐INDUCED URINARY BLADDER CARCINOGENESIS IN RATSActa Pathologica Japonica, 1982